Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1993-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.90.6.2495PMID 7681597PMCID PMC46114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins

  1992cited by this paper
• Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128).

  1991cited by this paper
• Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus

  1991cited by this paper
• Expression of the Tn antigen on T-lymphoid cell line Jurkat.

  1991cited by this paper
• A monoclonal antibody directed to Tn antigen.

  1990cited by this paper
• Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.

  1990cited by this paper
• Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.

  1989cited by this paper
• Production of Monoclonal Antibodies Directed against Carbohydrate Moieties of Cell Surface Glycoproteins

  1988cited by this paper
• Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions

  1987cited by this paper
• Isolation and characterization of human glycophorin A cDNA clones by a synthetic oligonucleotide approach: nucleotide sequence and mRNA structure.

  1986cited by this paper
• T and Tn, general carcinoma autoantigens.

  1984cited by this paper
• Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin.

  1975cited by this paper
• Cryptic A‐Like Receptor Sites in Human Erythrocyte Glycoproteins: Proposed Nature of Tn‐Antigen

  1974cited by this paper
• Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides.

  1969cited by this paper
• Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn).

  1959cited by this paper

• Deciphering Protein O-GalNAcylation: Method Development and Disease Implication

  2023cites this paper
• Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives

  2022cites this paper
• MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.

  2019cites this paper
• Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.

  2019cites this paper
• Relationship of epitope glycosylation and other properties of blood group proteins to the immunogenicity of blood group antigens

  2018cites this paper
• Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing

  2018cites this paper
• POLYVALENT CONJUGATE WACCINE FOR CANCER

  2017cites this paper
• Design and synthesis of multivalent glycoconjugates for anti-cancer immunotherapy

  2017cites this paper
• Anticorps anti-muc16 et utilisations

  2016cites this paper
• Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

  2016cites this paper
• Site‐specific analysis of von Willebrand factor O‐glycosylation

  2016cites this paper
• Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification

  2014cites this paper
• Mucin and Cancer

  2014cites this paper
• Modulation of glycan recognition by clustered saccharide patches.

  2014cites this paper
• Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer

  2013cites this paper
• HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.

  2013cites this paper
• Utilisation d'un anticorps monoclonal anti-Tn en immunothérapie des cancers

  2013cites this paper
• Chapter 375 – O-Sialoglycoprotein Endopeptidase

  2013cites this paper
• Glycan Microarray Analysis of Tumor-Associated Antibodies

  2012cites this paper
• Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.

  2012cites this paper
• Vaccines and Immunomodulation

  2012cites this paper
• Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.

  2012cites this paper
• Ikuo Yamashina: a pioneer who established the basis of current glycobiology.

  2012cites this paper
• Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.

  2012cites this paper
• Biomedical Applications of Peptide-, Glyco- and Glycopeptide Dendrimers, and Analogous Dendrimeric Structures

  2012cites this paper
• Review Special Focu S: Ta R ge T ed oncology

  2012cites this paper
• Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

  2012cites this paper
• Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.

  2012cites this paper
• Microenvironment and Immunology Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy

  2011cites this paper
• Characterization of three different single chain antibodies recognizing non-reducing terminal mannose residues expressed in Escherichia coli by an inducible T7 expression system.

  2011cites this paper
• DETECCIÓN DEL ANTÍGENO Tn EN TUMORES EPITELIALES CON LA LECTINA DE Vicia villosa isolectina B4

  2010cites this paper
• The trail of my studies on glycoproteins from enterokinase to tumor markers

  2010cites this paper
• LYMPHATIC SPREADING PROPENSITY

  2010cites this paper
• Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.

  2010cites this paper
• Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.

  2010cites this paper
• Effects of Hapten Density on the Induced Antibody Repertoire

  2010cites this paper
• A novel series of anti-human glycophorin A (CD235a) antibodies defining five extra- and intracellular epitopes.

  2010cites this paper
• Production of Anti-Carbohydrate Antibodies for Cancer Therapeutics or Diagnostics

  2010cites this paper
• Antibody recognition of a unique tumor-specific glycopeptide antigen

  2010cites this paper
• Expression of Tn and sialyl Tn antigens in synovial tissues in rheumatoid arthritis.

  2010cites this paper
• Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.

  2009cites this paper
• Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.

  2008cites this paper
• Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.

  2008cites this paper
• Glycopeptide dendrimers, Part III—a review: Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

  2008cites this paper
• Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21

  2007cites this paper
• Vaccination therapy in prostate cancer

  2007cites this paper
• 3.19 – Blood Group Antigens

  2007cites this paper
• Carbohydrate Vaccines Against Cancer

  2007cites this paper
• Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.

  2007cites this paper
• Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.

  2006cites this paper
• Synthetic Glycopeptide-Based Vaccines

  2006cites this paper
• Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?

  2006cites this paper
• [Characteristics of mucin produced by epithelial cancer cells and its biological significance in cancer tissue].

  2005cites this paper
• Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn

  2005cites this paper
• Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.

  2005influential citation
• Antibody inducing polyvalent cancer vaccines.

  2005cites this paper
• Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract

  2005cites this paper
• Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.

  2005cites this paper
• Further characterization of the binding properties of two monoclonal antibodies recognizing human Tn red blood cells.

  2005influential citation
• Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant

  2004cites this paper
• Novel glycoproteins inhibiting the binding of colorectal cancer cells to E-selectin

  2004cites this paper
• Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa

  2004cites this paper
• Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.

  2004cites this paper
• O -Sialoglycoprotein Endopeptidase

  2004cites this paper
• Antibody-Inducing Cancer Vaccines Against Cell-Surface Carbohydrate Antigens

  2004cites this paper
• A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

  2004cites this paper
• Cloning and Characterization of a New Human UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase, Designated pp-GalNAc-T13, That Is Specifically Expressed in Neurons and Synthesizes GalNAc α-Serine/Threonine Antigen*

  2003cites this paper
• Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.

  2003cites this paper
• Biochemical characterization of soluble Tn glycoproteins from malignant effusions of patients with carcinomas.

  2003cites this paper
• Novel approaches to treat asymptomatic, hormone-naive patients with rising prostate-specific antigen after primary treatment for prostate cancer.

  2003cites this paper
• Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.

  2003cites this paper
• SRCL/CL-P1 recognizes GalNAc and a carcinoma-associated antigen, Tn antigen.

  2003cites this paper
• Fully S ynthetic C arbohydrate-Bas ed V accines i n B iochemically Relapsed P rostate C ancer: C linical T rial R esults With - N -Acetylgalactosa mine- O -Serine/Threonin e Conjugate V accine

  2003cites this paper
• The role of glycosylation in protein antigenic properties

  2002cites this paper
• High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside.

  2002cites this paper
• The use of carbohydrate antigens for the preparation of vaccines for therapy in breast cancer.

  2002cites this paper
• The case for polyvalent cancer vaccines that induce antibodies

  2002cites this paper
• High-affinity binding of recombinant human galectin-4 to SO3–→3Galβ1→3GalNAc pyranoside

  2002cites this paper
• Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice

  2001cites this paper
• High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.

  2001cites this paper
• Identification of the core protein carrying the Tn antigen in mouse brain: specific expression on syndecan-3.

  2001cites this paper
• Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a TriTn TriTn TriTn Glycotope 1

  2001cites this paper
• Displaying a Tri-Tn Glycotope Synthetic Multiple Antigenic Glycopeptide Anti-Tumor Immunity

  2001cites this paper
• Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri-Tn Glycotope1

  2001cites this paper
• Developmental expression of a unique carbohydrate antigen, Tn antigen, in mouse central nervous tissues

  2001cites this paper
• Biochemical and functional characterization of the Tn-specific lectin from Salvia sclarea seeds.

  2000cites this paper
• Analysis of the fine specificity of Tn‐binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy

  2000cites this paper
• Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.

  2000cites this paper
• Production and Functional Characterization of Two Mouse/Human Chimeric Antibodies With Specificity for the Tumor-Associated Tn-Antigen

  2000cites this paper
• Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.

  2000cites this paper
• Probing cell-surface architecture through synthesis: an NMR-determined structural motif for tumor-associated mucins.

  1999cites this paper
• A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.

  1999cites this paper
• Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells

  1999cites this paper
• Specificity studies of an antibody developed against a mucin-type glycoprotein

  1999cites this paper
• Binding characteristics of an anti-Siaalpha2-6GalNAcalpha-Ser/Thr (sialyl Tn) monoclonal antibody (MLS 132).

  1999cites this paper
• Iron(II)-Assisted Assembly of Trivalent GalNAc Clusters and Their Interactions with GalNAc-Specific Lectins

  1999cites this paper
• Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.

  1998cites this paper
• Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting.

  1998cites this paper
• Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.

  1998cites this paper
• Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.

  1998cites this paper